| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| M J Kayath, E M Russo, S A Dib, J G Vieir. Do impaired glucose tolerance and diabetes mellitus interfere with the interpretation of the growth hormone response to the oral glucose tolerance test? Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. vol 25. issue 5. 1994-02-10. PMID:1342220. |
however, when suspected acromegaly is associated with diabetes mellitus (dm) or impaired glucose tolerance (igt) the interpretation of the gh response to the oral glucose tolerance test (ogtt) may be difficult. |
1994-02-10 |
2023-08-11 |
human |
| P J Selman, J A Mol, G R Rutteman, E van Garderen, A Rijnber. Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology. vol 134. issue 1. 1994-02-07. PMID:7506206. |
in the dog endogenous progesterone and synthetic progestins may incite overproduction of gh, resulting in acromegaly and insulin resistance. |
1994-02-07 |
2023-08-12 |
dog |
| K M Main, J Lindholm, M Vandeweghe, N E Skakkebae. Urinary growth hormone excretion in acromegaly: diagnostic value in mild disease activity. Acta endocrinologica. vol 129. issue 5. 1994-02-04. PMID:8279221. |
we therefore examined the diagnostic value of the measurement of urinary growth hormone (gh) excretion in seventy unselected patients with acromegaly of different activity by comparing it to serum gh, serum insulin-like growth factor i (igf-i) and clinical activity. |
1994-02-04 |
2023-08-12 |
Not clear |
| M B Rank. Effects of growth hormone on the metabolism of lipids and water and their potential in causing adverse events during growth hormone treatment. Hormone research. vol 39. issue 3-4. 1994-01-27. PMID:8262469. |
the risks faced in acromegaly, for instance, are not necessarily shared by turner's syndrome patients treated with gh. |
1994-01-27 |
2023-08-12 |
Not clear |
| J Bertherat, P Chanson, D Dewailly, M Dupuy, P Jaquet, F Peillon, J Epelbau. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas. The Journal of clinical endocrinology and metabolism. vol 77. issue 6. 1994-01-24. PMID:7903312. |
to determine the cellular mechanism(s) of the variability in gh responsiveness to octreotide in acromegaly, somatostatin (srih) receptor status was studied in 37 gh-secreting adenomas. |
1994-01-24 |
2023-08-12 |
Not clear |
| K Takan. [Recent progress in diagnosis and treatment of patients with GH deficiency and GH overproduction]. Nihon rinsho. Japanese journal of clinical medicine. vol 51. issue 10. 1994-01-10. PMID:8254939. |
the diagnostic criteria of gh deficiency and acromegaly have been revised in 1990 by the ministry of health and welfare in japan. |
1994-01-10 |
2023-08-12 |
Not clear |
| K Takan. [Recent progress in diagnosis and treatment of patients with GH deficiency and GH overproduction]. Nihon rinsho. Japanese journal of clinical medicine. vol 51. issue 10. 1994-01-10. PMID:8254939. |
for the treatment of gh producing pituitary tumor (acromegaly), a long acting analog of somatostatin is now available to reduce the size of the tumor. |
1994-01-10 |
2023-08-12 |
Not clear |
| E Hosoi, Y Yokogoshi, E Hosoi, H Horie, T Sano, S Yamada, S Sait. Analysis of the Gs alpha gene in growth hormone-secreting pituitary adenomas by the polymerase chain reaction-direct sequencing method using paraffin-embedded tissues. Acta endocrinologica. vol 129. issue 4. 1993-12-17. PMID:8237246. |
we investigated the prevalence of gs alpha gene mutations in growth hormone (gh) secreting pituitary adenomas from japanese patients with acromegaly. |
1993-12-17 |
2023-08-12 |
Not clear |
| A L Jensen, M K Thomsen, H Aaes, M Andreasen, J Søndergaar. Polymorphonuclear neutrophil granulocyte chemotactic hyperresponsiveness in a case of canine acromegaly. Veterinary immunology and immunopathology. vol 37. issue 3-4. 1993-12-14. PMID:8236807. |
the purpose of the present study was to evaluate the chemotactic responsiveness of canine peripheral pmn in a dog with acromegaly, caused by spontaneous, progesterone-induced hypersecretion of gh and, secondary to this, a seven-fold increase in insulin-like growth factor i (igf-i). |
1993-12-14 |
2023-08-12 |
dog |
| G Tamburrano, M L Jaffrain-Rea, A Grossi, A Lise, C Bullett. [Familial acromegaly. Apropos of a case. Review of the literature]. Annales d'endocrinologie. vol 53. issue 5-6. 1993-12-08. PMID:1364120. |
despite basal plasma gh levels ranging from 8.00 to 10.00 ng/ml in 3 other family members, the normality of both gh response to induced-hyperglycemia and ct-imaging of the pituitary gland excluded the diagnosis of acromegaly in these subjects. |
1993-12-08 |
2023-08-11 |
human |
| O Dohán, M Góth, I Szabolcs, L Kovács, Z Kovács, G Szilágy. [The place of insulin-like growth factor I in the diagnosis of acromegaly]. Orvosi hetilap. vol 134. issue 42. 1993-12-06. PMID:8233444. |
insulin-like growth factor-i (igf-i) and basal growth hormone (gh) (average of gh values measured at -20 an 0 minutes) levels were measured in 32 (29 treated, 3 untreated) patients with acromegaly. |
1993-12-06 |
2023-08-12 |
Not clear |
| O Dohán, M Góth, I Szabolcs, L Kovács, Z Kovács, G Szilágy. [The place of insulin-like growth factor I in the diagnosis of acromegaly]. Orvosi hetilap. vol 134. issue 42. 1993-12-06. PMID:8233444. |
compared to this, the basal gh level proved to be a much less reliable indicator to predict or exclude active acromegaly (sensitivity: 0.7, specificity: 1, positive predictive value: 1, negative predictive value: 0.75). |
1993-12-06 |
2023-08-12 |
Not clear |
| M Mauri, A M Picó, R Alfayate, J R Dominguez, R Cámara, C Miralle. Usefulness of urinary growth hormone (GH) measurement for evaluating endogenous GH secretion in acromegaly. Hormone research. vol 39. issue 1-2. 1993-11-10. PMID:8406334. |
usefulness of urinary growth hormone (gh) measurement for evaluating endogenous gh secretion in acromegaly. |
1993-11-10 |
2023-08-12 |
Not clear |
| M Mauri, A M Picó, R Alfayate, J R Dominguez, R Cámara, C Miralle. Usefulness of urinary growth hormone (GH) measurement for evaluating endogenous GH secretion in acromegaly. Hormone research. vol 39. issue 1-2. 1993-11-10. PMID:8406334. |
in conclusion, u-gh appears to be a simple, noninvasive and inexpensive test for evaluating gh secretion in active acromegaly. |
1993-11-10 |
2023-08-12 |
Not clear |
| S Ohashi, H Kaji, H Abe, K Chihar. "Paradoxical" GH suppression by secretagogues in acromegaly? Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. vol 25. issue 7. 1993-11-08. PMID:8406329. |
"paradoxical" gh suppression by secretagogues in acromegaly? |
1993-11-08 |
2023-08-12 |
Not clear |
| D K Alster, C Y Bowers, C A Jaffe, P J Ho, A L Barka. The growth hormone (GH) response to GH-releasing peptide (His-DTrp-Ala-Trp-DPhe-Lys-NH2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly. The Journal of clinical endocrinology and metabolism. vol 77. issue 3. 1993-10-14. PMID:8370708. |
the growth hormone (gh) response to gh-releasing peptide (his-dtrp-ala-trp-dphe-lys-nh2), gh-releasing hormone, and thyrotropin-releasing hormone in acromegaly. |
1993-10-14 |
2023-08-12 |
Not clear |
| D K Alster, C Y Bowers, C A Jaffe, P J Ho, A L Barka. The growth hormone (GH) response to GH-releasing peptide (His-DTrp-Ala-Trp-DPhe-Lys-NH2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly. The Journal of clinical endocrinology and metabolism. vol 77. issue 3. 1993-10-14. PMID:8370708. |
in patients with acromegaly, gh-producing pituitary tumors release gh in response to specific stimuli such as gh-releasing hormone (ghrh) and are also responsive to a variety of nonspecific stimuli, such as trh or gnrh, and may exhibit paradoxical responses to glucose and dopamine. |
1993-10-14 |
2023-08-12 |
Not clear |
| D K Alster, C Y Bowers, C A Jaffe, P J Ho, A L Barka. The growth hormone (GH) response to GH-releasing peptide (His-DTrp-Ala-Trp-DPhe-Lys-NH2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly. The Journal of clinical endocrinology and metabolism. vol 77. issue 3. 1993-10-14. PMID:8370708. |
we studied the gh responses to ghrh, ghrp, and trh stimulation in 11 patients with active acromegaly. |
1993-10-14 |
2023-08-12 |
Not clear |
| D K Alster, C Y Bowers, C A Jaffe, P J Ho, A L Barka. The growth hormone (GH) response to GH-releasing peptide (His-DTrp-Ala-Trp-DPhe-Lys-NH2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly. The Journal of clinical endocrinology and metabolism. vol 77. issue 3. 1993-10-14. PMID:8370708. |
in conclusion, in patients with acromegaly, the gh response to ghrp is qualitatively normal and does not appear to depend on ghrh. |
1993-10-14 |
2023-08-12 |
Not clear |
| S Melme. Medical management of acromegaly--what and when? Acta endocrinologica. vol 129 Suppl 1. 1993-10-14. PMID:8372605. |
gh and igf-i levels are elevated in patients with acromegaly. |
1993-10-14 |
2023-08-12 |
Not clear |